These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7875183)

  • 1. Acute effect of ibopamine and isosorbide mononitrate on blood volume distribution in congestive heart failure.
    Holman ND; Hoekstra OS; Groeneveld AB; Schneider AJ; de Voogt WG; van der Meer J
    Eur J Clin Pharmacol; 1994; 47(4):325-30. PubMed ID: 7875183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a single oral dose of isorsorbide 5-mononitrate in normal dogs and in dogs with congestive heart failure.
    Adin DB; Kittleson MD; Hornof WJ; Kass PH
    J Vet Intern Med; 2001; 15(2):105-11. PubMed ID: 11300592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic drugs in congestive heart failure: hemodynamic and neuroendocrine responses to ibopamine, dopamine, and dihydroergotoxine.
    Metra M; Missale C; Spano PF; Cas LD
    J Cardiovasc Pharmacol; 1995 May; 25(5):732-40. PubMed ID: 7630152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute hemodynamic effects of ibopamine, captopril, and placebo in patients with severe heart failure].
    Cantarelli MJ; Carvalho AC; de Almeida DR; Azevedo JE; Smith AC; Campos Filho O; Martinez Filho EE
    Arq Bras Cardiol; 1995 Apr; 64(4):335-9. PubMed ID: 7495392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study.
    G Ital Cardiol; 1989 Jan; 19(1):71-80. PubMed ID: 2663585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of a possible pharmacokinetic interaction between ibopamine and isosorbide-5-mononitrate.
    Lefebvre RA; De Wilde G; Rosseel MT; Duprez D; De Sutter J; Pocchiari F
    Eur J Clin Pharmacol; 1992; 42(5):549-52. PubMed ID: 1607003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dopamine congener, ibopamine, in congestive heart failure.
    Ren JH; Unverferth DV; Leier CV
    J Cardiovasc Pharmacol; 1984; 6(5):748-55. PubMed ID: 6209476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive pharmacodynamic characterization of combined ibopamine and calcium blocker therapy for heart failure.
    Munger MA; Nara AR; Pospisil RA; Stoddard GJ; Schleman M
    Pharmacotherapy; 1993; 13(3):218-23. PubMed ID: 8100627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of ibopamine on glomerular filtration rate and plasma norepinephrine remain preserved during prolonged treatment in patients with congestive heart failure.
    Lieverse AG; Girbes AR; Van Veldhuisen DJ; Smit AJ; Zijlstra JG; Meijer S; Lie KI; Reitsma WD
    Eur Heart J; 1995 Jul; 16(7):937-42. PubMed ID: 7498209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acute and chronic ibopamine administration on resting and exercise hemodynamics, plasma catecholamines and functional capacity of patients with chronic congestive heart failure.
    Dei Cas L; Metra M; Visioli O
    Am J Cardiol; 1992 Sep; 70(6):629-34. PubMed ID: 1354938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT).
    van Veldhuisen DJ; Man in 't Veld AJ; Dunselman PH; Lok DJ; Dohmen HJ; Poortermans JC; Withagen AJ; Pasteuning WH; Brouwer J; Lie KI
    J Am Coll Cardiol; 1993 Nov; 22(6):1564-73. PubMed ID: 7901256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal and systemic hemodynamic effects of ibopamine in patients with mild to moderate congestive heart failure.
    Lieverse AG; van Veldhuisen DJ; Smit AJ; Zijlstra JG; Meijer S; Reitsma WD; Lie KI; Girbes AR
    J Cardiovasc Pharmacol; 1995 Mar; 25(3):361-7. PubMed ID: 7769799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isosorbide-5-mononitrate in the treatment of acute left ventricular failure following acute myocardial infarction.
    Gammage MD; Murray RG; Littler WA
    Eur J Clin Pharmacol; 1986; 29(6):639-43. PubMed ID: 3709607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure.
    Andrews R; Charlesworth A; Evans A; Cowley AJ
    Eur Heart J; 1997 May; 18(5):852-7. PubMed ID: 9152656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study.
    Lewis BS; Rabinowitz B; Schlesinger Z; Caspi A; Markiewicz W; Rosenfeld T; Sclarovsky S; Ermer W
    Cardiology; 1999; 91(1):1-7. PubMed ID: 10393392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral hemodynamic effects of ibopamine in patients with congestive heart failure. A placebo-controlled, double-blind study.
    Longhini C; Ansani L; Musacci GF; Aggio S; Baracca E; Toselli T; Ghirardi P
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):199-202. PubMed ID: 2487532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
    Dei Cas L; Metra M; Nodari S; Visioli O
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S111-7. PubMed ID: 2483436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.
    Gavazzi A; Mussini A; Bramucci E
    Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute haemodynamic effects of ibopamine in patients with severe congestive heart failure.
    Ghirardi P; Brusoni B; Mangiavacchi M; Bianco L; Col J; Metra M; Dei Cas L
    Br J Clin Pharmacol; 1985 May; 19(5):613-8. PubMed ID: 4005102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
    Sannia L; Ibba GV; Castellaccio M; Dore L
    Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.